Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
F Behrens, M Koehm, EC Schwaneck, M Schmalzing, BM Wittig, H Gnann, G Greger, H-P Tony & H Burkhardt. (2019) Addition or removal of concomitant methotrexate alters adalimumab effectiveness in rheumatoid arthritis but not psoriatic arthritis. Scandinavian Journal of Rheumatology 48:5, pages 375-382.
Read now
Read now
Michael Ruberson Ribeiro da Silva, Jéssica Barreto Ribeiro dos Santos, Alessandra Maciel Almeida, Augusto Afonso Guerra Júnior, Juliana Alvares Teodoro & Francisco de Assis Acurcio. (2019) Biological therapy in the treatment of psoriatic arthritis: economic and epidemiological considerations. Expert Review of Clinical Immunology 15:8, pages 879-887.
Read now
Read now
Articles from other publishers (28)
Louise Linde, Lykke M Ørnbjerg, Stylianos Georgiadis, Simon H. Rasmussen, Ulf Lindström, Johan Askling, Brigitte Michelsen, Daniela Di Giuseppe, Johan K Wallman, Bjorn Gudbjornsson, Thorvardur Jon Love, Dan C Nordström, Timo Yli-Kerttula, Lucie Nekvindová, Jiří Vencovský, Florenzo Iannone, Alberto Cauli, Anne Gitte Loft, Bente Glintborg, Karin Laas, Ziga Rotar, Matija Tomšič, Gary J Macfarlane, Burkhard Möller, Marleen van de Sande, Catalin Codreanu, Michael J Nissen, Merih Birlik, Sukran Erten, Maria J Santos, Elsa Vieira-Sousa, Merete L Hetland & Mikkel Østergaard. (2023) Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor: results from 13 European registries. Rheumatology.
Crossref
Crossref
Sanjana Tarannum, Ying-Ying Leung, Sindhu R. Johnson, Jessica Widdifield, Vibeke Strand, Paula Rochon & Lihi Eder. (2022) Sex- and gender-related differences in psoriatic arthritis. Nature Reviews Rheumatology 18:9, pages 513-526.
Crossref
Crossref
SehamR Alunizi, AlRabbab AlShanqeeti, KhalidahA Alenzi & IbrahimAbdulrazag Al-Homood. (2022) Psoriatic arthritis: Saudi retrospective observational study of manifestations and treatments. Annals of Rheumatology and Autoimmunity 2:2, pages 53.
Crossref
Crossref
Ashley Elliott, Dennis McGonagle & Madeleine Rooney. (2021) Integrating imaging and biomarker assessment to better define psoriatic arthritis and predict response to biologic therapy. Rheumatology 60:Supplement_6, pages vi38-vi52.
Crossref
Crossref
Mariagrazia Lorenzin, Augusta Ortolan, Giacomo Cozzi, Antonia Calligaro, Maria Favaro, Teresa Del Ross, Andrea Doria & Roberta Ramonda. (2021) Predictive factors for switching in patients with psoriatic arthritis undergoing anti-TNFα, anti-IL12/23, or anti-IL17 drugs: a 15-year monocentric real-life study. Clinical Rheumatology 40:11, pages 4569-4580.
Crossref
Crossref
Peter Hur, Nina Kim, Dong Dai, Olivia W. Piao, Josh Z. Zheng & Esther Yi. (2020) Healthcare Cost and Utilization Associated with Biologic Treatment Patterns Among Patients with Psoriatic Arthritis: Analyses from a Large US Claims Database. Drugs - Real World Outcomes 8:1, pages 29-38.
Crossref
Crossref
Kirk Geale, Ingrid Lindberg, Emma C Paulsson, E Christina M Wennerström, Anna Tjärnlund, Wim Noel, Dana Enkusson & Elke Theander. (2020) Persistence of biologic treatments in psoriatic arthritis: a population-based study in Sweden. Rheumatology Advances in Practice 4:2.
Crossref
Crossref
Elsa Vieira-Sousa, Mónica Eusébio, Pedro Ávila-Ribeiro, Nikita Khmelinskii, Rita Cruz-Machado, Teresa Martins Rocha, Miguel Bernardes, Daniela Santos-Faria, Joana Leite Silva, Helena Santos, Cláudia Miguel, Pedro Carvalho, Tiago Costa, Ana Catarina Duarte, Tiago Meirinhos, Patrícia Nero, João Eurico Fonseca & Maria José Santos. (2020) Real-world Longterm Effectiveness of Tumor Necrosis Factor Inhibitors in Psoriatic Arthritis Patients from the Rheumatic Diseases Portuguese Register. The Journal of Rheumatology 47:5, pages 690-700.
Crossref
Crossref
Maria Antonietta Barbieri, Giuseppe Cicala, Paola Maria Cutroneo, Elisabetta Gerratana, Caterina Palleria, Caterina De Sarro, Ada Vero, Luigi Iannone, Antonia Manti, Emilio Russo, Giovambattista De Sarro, Fabiola Atzeni & Edoardo Spina. (2020) Safety Profile of Biologics Used in Rheumatology: An Italian Prospective Pharmacovigilance Study. Journal of Clinical Medicine 9:4, pages 1227.
Crossref
Crossref
Philip J. Mease, Neil A. Accortt, Sabrina Rebello, Carol J. Etzel, Ryan W. Harrison, Girish A. Aras, Mahdi M. F. Gharaibeh, Jeffrey D. Greenberg & David H. Collier. (2019) Persistence of tumor necrosis factor inhibitor or conventional synthetic disease-modifying antirheumatic drug monotherapy or combination therapy in psoriatic arthritis in a real-world setting. Rheumatology International 39:9, pages 1547-1558.
Crossref
Crossref
Jessica Polo y La Borda, José Campos, Jesús Sanz, José Luis Andréu, Juan Mulero & Alejandra Sánchez. (2019) Predictive clinical‐genetic model of long‐term non‐response to tumor necrosis factor‐alpha inhibitor therapy in spondyloarthritis. International Journal of Rheumatic Diseases.
Crossref
Crossref
Alexis Ogdie, J. Lynn Palmer, Jeffrey Greenberg, Jeffrey R. Curtis, Leslie R. Harrold, Daniel H. Solomon, Arthur Kavanaugh, Joel M. Kremer & Philip J. Mease. (2019) Predictors of Achieving Remission among Patients with Psoriatic Arthritis Initiating a Tumor Necrosis Factor Inhibitor. The Journal of Rheumatology 46:5, pages 475-482.
Crossref
Crossref
Michael Ruberson Ribeiro da Silva, Jéssica Barreto Ribeiro dos Santos, Alessandra Maciel Almeida, Alexander Itria, Adriana Maria Kakehasi, Juliana Alvares Teodoro & Francisco de Assis Acurcio. (2019) Medication persistence for psoriatic arthritis in a Brazilian real-world setting. Future Science OA 5:2.
Crossref
Crossref
Josef S Smolen, Dafna Gladman, H Patrick McNeil, Philip J Mease, Joachim Sieper, Maja Hojnik, Pascal Nurwakagari & John Weinman. (2019) Predicting adherence to therapy in rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis: a large cross-sectional study. RMD Open 5:1, pages e000585.
Crossref
Crossref
Antonio Marchesoni. (2018) Oligoarticular Psoriatic Arthritis: Addressing Clinical Challenges in an Intriguing Phenotype. Rheumatology and Therapy 5:2, pages 311-316.
Crossref
Crossref
Gustavo Deza, Jaime Notario, Marta Ferran, Emma Beltrán, Miriam Almirall, Rebeca Alcalá, José Carlos Ruiz-Carrascosa, Ricardo Sánchez, Silvia Pérez, María Luz García-Vivar, Eva Galíndez, Maribel Mora, Jesús Rodríguez & Fernando Gallardo. (2018) Long-term etanercept survival in patients with psoriatic arthritis: a multicenter retrospective analysis in daily clinical practice in Spain. Rheumatology International 38:11, pages 2037-2043.
Crossref
Crossref
Gavin Clunie, Iain B McInnes, Nick Barkham, Helena Marzo-Ortega, Yusuf Patel, Andrew Gough, Jon Packham, Stuart Kyle, Bruce Kirkham, Tom Sheeran, Helen Coope, Anna Bishop-Bailey & Neil McHugh. (2018) Long-term effectiveness of tumour necrosis factor-α inhibitor treatment for psoriatic arthritis in the UK: a multicentre retrospective study. Rheumatology Advances in Practice 2:2.
Crossref
Crossref
Ying-Yan Zhou, Xuan Xia, Wen-Ke Peng, Qin-He Wang, Jian-Hong Peng, Yan-lin Li, Jian-Xiong Wu, Jian-Yong Zhang, Yue Zhao, Xiu-Min Chen, Run-Yue Huang, Per-Johan Jakobsson, Ze-Huai Wen & Qing-Chun Huang. (2018) The Effectiveness and Safety of Tripterygium wilfordii Hook. F Extracts in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology 9.
Crossref
Crossref
Kathleen Tymms, Ayano Kelly, Paul Bird, Hedley Griffiths, Julien de Jager, Geoff Littlejohn, Sandra Louw, Lynden Roberts, Peter Youssef, Jane Zochling & Dave Nichols. (2018) Psoriatic arthritis treatment regimens, therapy duration and reasons for cessation in the biologics era: a multi-centre Australian study. International Journal of Rheumatic Diseases 21:2, pages 510-516.
Crossref
Crossref
Sivan Sheffer Levi & Yuval Ramot. 2018. Gender and Dermatology. Gender and Dermatology
63
81
.
Luisa Costa, Carlo Perricone, Maria Sole Chimenti, Antonio Del Puente, Paolo Caso, Rosario Peluso, Paolo Bottiglieri, Raffaele Scarpa & Francesco Caso. (2017) Switching Between Biological Treatments in Psoriatic Arthritis: A Review of the Evidence. Drugs in R&D 17:4, pages 509-522.
Crossref
Crossref
Mark Corbett, Fadi Chehadah, Mousumi Biswas, Thirimon Moe-Byrne, Stephen Palmer, Marta Soares, Matthew Walton, Melissa Harden, Pauline Ho, Nerys Woolacott & Laura Bojke. (2017) Certolizumab pegol and secukinumab for treating active psoriatic arthritis following inadequate response to disease-modifying antirheumatic drugs: a systematic review and economic evaluation. Health Technology Assessment 21:56, pages 1-326.
Crossref
Crossref
Fabrizio Cantini, Laura Niccoli, Carlotta Nannini, Emanuele Cassarà, Olga Kaloudi, Ennio Giulio Favalli, Andrea Becciolini, Maurizio Benucci, Francesca Li Gobbi, Serena Guiducci, Rosario Foti, Marta Mosca & Delia Goletti. (2017) Second-line biologic therapy optimization in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. Seminars in Arthritis and Rheumatism 47:2, pages 183-192.
Crossref
Crossref
Ennio Giulio Favalli, Carlo Selmi, Andrea Becciolini, Martina Biggioggero, Alarico Ariani, Daniele Santilli, Enrico Fusaro, Simone Parisi, Marco Massarotti, Antonio Marchesoni & Pier Luigi Meroni. (2017) Eight-Year Retention Rate of First-Line Tumor Necrosis Factor Inhibitors in Spondyloarthritis: A Multicenter Retrospective Analysis. Arthritis Care & Research 69:6, pages 867-874.
Crossref
Crossref
Alexis Ogdie & Laura Coates. (2017) The Changing Face of Clinical Trials in Psoriatic Arthritis. Current Rheumatology Reports 19:4.
Crossref
Crossref
Florenzo Iannone, Simona Lopriore, Romano Bucci, Giuseppe Lopalco, Angela Chialà, Luca Cantarini & Giovanni Lapadula. (2016) Longterm Clinical Outcomes in 420 Patients with Psoriatic Arthritis Taking Anti-tumor Necrosis Factor Drugs in Real-world Settings. The Journal of Rheumatology 43:5, pages 911-917.
Crossref
Crossref
Alejandro Souto, José Ramón Maneiro & Juan J. Gómez-Reino. (2015) Rate of discontinuation and drug survival of biologic therapies in rheumatoid arthritis: a systematic review and meta-analysis of drug registries and health care databases. Rheumatology, pages kev374.
Crossref
Crossref
Inesa Arštikytė, Irena Butrimienė & Algirdas Venalis. (2015) Autoimuniniu artritu sergančių biologine terapija gydomų pacientų stebėjimo duomenys (lietuvos reumatinių ligų biologinės terapijos duomenų bazės duomenys). Medicinos teorija ir praktika 21:3.2, pages 390-405.
Crossref
Crossref